Skip to main content
All lobbying filings

GUTTMACHER INSTITUTE

Lobbying for GUTTMACHER INSTITUTE

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $9,749.16 expenses · posted Jul 20, 2026

Official filing document

 Bills named in this filing 11
  • HR 4611
    EACH Act of 2025
  • HRES 1389
    Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponi…
  • SRES 732
    A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed…
  • HRES 1285
    Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-rev…
  • S 4701
    Freedom to Travel for Health Care Act of 2026
  • HR 9470
    SAFER Health Act of 2026
  • S 4922
    Reproductive Health Travel Fund Act of 2026
  • HR 9441
    SAFE Training for OB-GYNs Act
  • HR 999
    Right to Contraception Act
  • HR 8582
    Protecting Human Rights and Public Health in Foreign Assistance Act
  • S 4426
    STOP Act
 Lobbying activity 4
Budget/Appropriations

FY 27 Appropriations- Emailed Senate offices to sign on to FY 27 international family planning/reproductive health - Signed on to a FY 27 appropriations letter urging the House to support reproductive health and rights priorities - Signed on to a FY 27 appropriations letter to the House supporting funding for domestic family planning programs

Family issues/Abortion/Adoption

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- urged House and Senate offices to cosponsor the bill -H.Res.1389 Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care- met with staff and drafted text -Reproductive Health Travel Fund Act (not yet introduced)- worked on drafting text -S.Res.732 / H.Res.1285 Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. Reviewed and endorsed legislation -S.4701 Freedom to Travel for Health Care Act of 2026- Reviewed and endorsed legislation - Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - S.4701 Freedom to Travel for Health Care Act of 2026- Made social media in support of bill, social media content development -S. 4922- Reproductive Health Travel Fund Act of 2026- social media content development - H.R. 9441- SAFE Training for OBGYNs Act- Endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff to discuss bill reintroduction

Foreign Relations

-Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff from Rep. Schakowsky's offices to discuss reintroduction of bill -H.R 8582/ S. 4426- Protecting Human Rights and Public Health in Foreign Assistance Act- Endorsed bill, emailed staff to cosponsor bill, social media content and development, met with colleagues to discuss advocacy strategies

Health Issues

- Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - S.4701 Freedom to Travel for Health Care Act of 2026- social media content development

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem